Genpharmasec Ltd vs GMR Airports Ltd

A side-by-side comparison of Genpharmasec Ltd (GENPHARMA) and GMR Airports Ltd (GMRAIRPORT) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, GMR Airports Ltd leads GENPHARMA vs GMRAIRPORT on 10 of 14 metrics (2 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

53.50
P/E ratio
655.76
0.88
P/B ratio
-47.63
0.00%
Dividend yield
0.00%
₹0.02
EPS
₹0.17

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

1.89%
Return on equity
45.67%
3.00%
Return on capital
12.00%
0.00%
EBITDA margin
39.00%
2.94%
Net margin
3.19%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

75.25%
Revenue CAGR (3Y)
30.42%
Profit CAGR (3Y)

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹58 Cr
Market cap
₹1.17L Cr
₹34 Cr
Revenue
₹14,807 Cr
₹1 Cr
Net profit
₹472 Cr
0.53
Debt / equity
0.00
Genpharmasec Ltd
  • + ["Stock is trading at 0.88 times its book value", "Company is expected to give good quarter", "Debtor days have improved from 111 to 76.3 days.", "Company's working capital requirements have reduced from 136 days to 61.1 days"]
  • ["Though the company is reporting repeated profits, it is not paying out dividend", "Company has low interest coverage ratio.", "Promoter holding is low: 30.0%", "Company has a low return on equity of 1.56% over last 3 years.", "Company might be capitalizing the interest cost", "Earnings include an other income of Rs.3.16 Cr.", "Promoter holding has decreased over last 3 years: -30.0%"]
GMR Airports Ltd
  • + ["Company is expected to give good quarter"]
  • ["Company has low interest coverage ratio."]
Genpharmasec Ltd full analysis GMR Airports Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.